1. Home
  2. CTKB vs NLOP Comparison

CTKB vs NLOP Comparison

Compare CTKB & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • NLOP
  • Stock Information
  • Founded
  • CTKB 1990
  • NLOP N/A
  • Country
  • CTKB United States
  • NLOP United States
  • Employees
  • CTKB N/A
  • NLOP N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NLOP
  • Sector
  • CTKB Health Care
  • NLOP
  • Exchange
  • CTKB Nasdaq
  • NLOP Nasdaq
  • Market Cap
  • CTKB 430.6M
  • NLOP 498.8M
  • IPO Year
  • CTKB 2021
  • NLOP N/A
  • Fundamental
  • Price
  • CTKB $4.01
  • NLOP $33.12
  • Analyst Decision
  • CTKB Hold
  • NLOP Strong Buy
  • Analyst Count
  • CTKB 4
  • NLOP 1
  • Target Price
  • CTKB $6.00
  • NLOP $46.00
  • AVG Volume (30 Days)
  • CTKB 1.2M
  • NLOP 111.1K
  • Earning Date
  • CTKB 08-06-2025
  • NLOP 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • NLOP 1.03%
  • EPS Growth
  • CTKB N/A
  • NLOP N/A
  • EPS
  • CTKB N/A
  • NLOP N/A
  • Revenue
  • CTKB $196,035,000.00
  • NLOP $117,598,000.00
  • Revenue This Year
  • CTKB $0.74
  • NLOP N/A
  • Revenue Next Year
  • CTKB $7.85
  • NLOP N/A
  • P/E Ratio
  • CTKB N/A
  • NLOP N/A
  • Revenue Growth
  • CTKB N/A
  • NLOP N/A
  • 52 Week Low
  • CTKB $2.37
  • NLOP $26.10
  • 52 Week High
  • CTKB $7.63
  • NLOP $34.53
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 59.09
  • NLOP 49.56
  • Support Level
  • CTKB $3.68
  • NLOP $32.45
  • Resistance Level
  • CTKB $4.19
  • NLOP $34.24
  • Average True Range (ATR)
  • CTKB 0.21
  • NLOP 0.75
  • MACD
  • CTKB 0.02
  • NLOP -0.06
  • Stochastic Oscillator
  • CTKB 76.16
  • NLOP 36.01

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.

Share on Social Networks: